![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
X
Highest Development Status: Phase I
Therapeutic Area: Endocrinology
Interventions: Exenatide
Product Type: Large molecule
Sponsor: Oramed Inc
Receptors: Glucagon-like peptide 1 recept...
Trial ID: NA
Location: NA
Condition: Type 2 diabetes mellitus
Product Status: Approved
Dosage Form: Capsule
Collaborator: NA
Recruitment Status: NA
Date Of Registration: NA
Product Description: ORMD-0901 (Exenatide), a GLP-1 analog, is based on Oramed
PharmaCompass >>